Tirzepatide pens contain a lyophilized powder form of the dual GIP and GLP-1 receptor agonist for research applications. The product is supplied in sterile vials with purity exceeding 99%.
Each tirzepatide pen contains the active pharmaceutical ingredient with molecular formula C225H348N48O68 and molecular weight of 4813. The product is carefully processed under controlled conditions to ensure stability and performance in research settings.
Our tirzepatide pens are manufactured under strict quality control standards. The lyophilization process preserves the peptide's activity while extending shelf life. Researchers can reconstitute the powder with appropriate solvents when ready for use.
Key features of our tirzepatide pens include ultra-low temperature processing to maintain peptide integrity, precise dosing in sterile vials, and batch-to-batch consistency. The product is intended solely for laboratory research purposes.
As a professional supplier, we offer tirzepatide pens in various configurations to meet different research requirements. Our manufacturing capabilities allow for custom formulations and bulk quantities while maintaining the highest quality standards.